AARDVARK THERAPEUTICS, INC. (AARD) Return on equity
AARDVARK THERAPEUTICS, INC. (AARD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-54.0%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -54.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AARD financial trends
AARD RevenueAARD Net incomeAARD Net marginAARD Gross profitAARD Gross marginAARD Operating incomeAARD Operating marginAARD Operating cash flowAARD Free cash flowAARD Capital expendituresAARD Stock buybacksAARD Dividends paidAARD Total assetsAARD Total liabilitiesAARD Shareholders’ equityAARD overview →